Funded Tech Companies
Myosana Therapeutics
Myosana Therapeutics, based in Seattle, raised money through Muscular Dystrophy Association, Parent Project Muscular Dystrophy and CureDuchenne Ventures.
Company Overview
Company Name
Myosana Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2617 Nw 59th St. 102
Seattle, WA 98107
USA
Seattle, WA 98107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity and reduce the disease burden of Duchenne muscular dystrophy (DMD) and other neuromuscular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/25/2023
Financing History
Management Team
Title
Name
Email & Social
Chairman
Stan Froehner
Chief Executive Officer
Steve Runnels
Chief Scientific Officer
Nick Whitehead
VP - R & D
Min Kim
Company Investors
- Muscular Dystrophy Association
- Parent Project Muscular Dystrophy
- CureDuchenne Ventures (Debra Miller)
- Private Investors (John Ballantyne)
Browse more funded tech companies:
Myonexus Therapeutics | MyoScience
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs